Inomax

Product manufactured by Ino Therapeutics

Application Nr Approved Date Route Status External Links
NDA020845 None Respiratory (Inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Inomax ® Is Indicated To Improve Oxygenation And Reduce The Need For Extracorporeal Membrane Oxygenation In Term And Near-Term (>34 Weeks Gestation) Neonates With Hypoxic Respiratory Failure Associated With Clinical Or Echocardiographic Evidence Of Pulmonary Hypertension In Conjunction With Ventilatory Support And Other Appropriate Agents. Inomax Is A Vasodilator Indicated To Improve Oxygenation And Reduce The Need For Extracorporeal Membrane Oxygenation In Term And Near-Term (>34 Weeks Gestation) Neonates With Hypoxic Respiratory Failure Associated With Clinical Or Echocardiographic Evidence Of Pulmonary Hypertension In Conjunction With Ventilatory Support And Other Appropriate Agents.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Nitric Oxide

Comments